Literature DB >> 30541751

A Linkage Between Thyroid and Breast Cancer: A Common Etiology?

Eric L Bolf1,2, Brian L Sprague2,3,4, Frances E Carr5,2.   

Abstract

Breast and thyroid cancers are two malignancies with highest incidence in women. These cancers often occur metachronously. Women with thyroid cancer are at increased risk for subsequent breast cancer; women with breast cancer have an increased incidence of later development of thyroid cancer, suggesting a common etiology. This bidirectional relationship is reported worldwide; however, the underlying reasons for this co-occurrence are unknown. In this review, we summarize the current epidemiologic evidence and putative mechanisms of these metachronous or synchronous cancers. Key potential causative factors are chemotherapy and radiotherapy of the primary tumor, genetic variants linking the two diseases, hormonal signaling both from the thyroid gland and from estrogens, and lifestyle and environmental factors. There is a critical need for additional epidemiologic studies focused on gender and regional incidence together with molecular investigations on common tumorigenic pathways in these endocrine cancers. Understanding the putative mechanisms will aid in the diagnosis and clinical management of both diseases. ©2018 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2018        PMID: 30541751     DOI: 10.1158/1055-9965.EPI-18-0877

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  23 in total

1.  Occurrence of Second Primary Malignancies in Patients With Primary Optic Nerve Gliomas: A Surveillance, Epidemiology, and End Results Analysis.

Authors:  Zain Hussain; Jawad Khan; Amir Saeed; Fatma Dihowm
Journal:  Cancer Diagn Progn       Date:  2021-11-03

2.  Common tumor-suppressive signaling of thyroid hormone receptor beta in breast and thyroid cancer cells.

Authors:  Eric L Bolf; Noelle E Gillis; Cole D Davidson; Lauren M Cozzens; Sophie Kogut; Jennifer A Tomczak; Seth Frietze; Frances E Carr
Journal:  Mol Carcinog       Date:  2021-09-17       Impact factor: 4.784

3.  Epidemiology of Thyroid Cancer.

Authors:  Cari M Kitahara; Arthur B Schneider
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2022-07-01       Impact factor: 4.090

Review 4.  Thyroid receptor β might be responsible for breast cancer associated with Hashimoto's thyroiditis: a new insight into pathogenesis.

Authors:  Muskaan Dhingra; Shayon Mahalanobis; Asmita Das
Journal:  Immunol Res       Date:  2022-05-13       Impact factor: 4.505

5.  Breast and thyroid cancer: A multicenter study with Accrual to Clinical Trials Network.

Authors:  Merry Peckham; Horace J Spencer; Shorabuddin Syed; William B Armstrong; Donald Gregory Farwell; Thomas J Gal; David Goldenberg; Marika D Russell; Roberto N Solis; Deanne King; Brendan C Stack
Journal:  J Surg Oncol       Date:  2022-02-23       Impact factor: 2.885

6.  Risk of second primary papillary thyroid cancer among adult cancer survivors in the United States, 2000-2015.

Authors:  Sara J Schonfeld; Lindsay M Morton; Amy Berrington de González; Rochelle E Curtis; Cari M Kitahara
Journal:  Cancer Epidemiol       Date:  2019-12-26       Impact factor: 2.984

7.  The Thyroid Hormone Receptor-RUNX2 Axis: A Novel Tumor Suppressive Pathway in Breast Cancer.

Authors:  Eric L Bolf; Noelle E Gillis; Michael S Barnum; Caitlin M Beaudet; Grace Y Yu; Jennifer A Tomczak; Janet L Stein; Jane B Lian; Gary S Stein; Frances E Carr
Journal:  Horm Cancer       Date:  2019-12-21       Impact factor: 3.869

8.  Association Between the Presence of Female-Specific Tumors and Aggressive Clinicopathological Features in Papillary Thyroid Cancer: A Retrospective Analysis of 9,822 Cases.

Authors:  Jiao Zhang; Le Zhou; Gianlorenzo Dionigi; Daqi Zhang; Lina Zhao; Nan Liang; Gaofeng Xue; Hui Sun
Journal:  Front Oncol       Date:  2021-03-11       Impact factor: 6.244

9.  Assessment of surveillance versus etiologic factors in the reciprocal association between papillary thyroid cancer and breast cancer.

Authors:  Pragati G Advani; Lindsay M Morton; Cari M Kitahara; Amy Berrington de Gonzalez; Cody Ramin; Megan R Haymart; Rochelle E Curtis; Sara J Schonfeld
Journal:  Cancer Epidemiol       Date:  2021-07-16       Impact factor: 2.890

10.  AK4 Promotes the Progression of HER2-Positive Breast Cancer by Facilitating Cell Proliferation and Invasion.

Authors:  Jie Zhang; Yan-Tao Yin; Chi-Hua Wu; Rong-Lin Qiu; Wen-Jun Jiang; Xiao-Geng Deng; Zhi-Xi Li
Journal:  Dis Markers       Date:  2019-11-20       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.